Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ALBANY, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 33rd Annual Canaccord Growth Conference on Wednesday, August 14, 2013, at 5 p.m. Eastern Time in Boston, Mass. Mark Frost, Executive Vice President and Chief Financial Officer, will review the Company's business strategy and recent corporate developments.
Help employers find you! Check out all the jobs and post your resume.
ALBANY, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the 33rd Annual Canaccord Growth Conference on Wednesday, August 14, 2013, at 5 p.m. Eastern Time in Boston, Mass. Mark Frost, Executive Vice President and Chief Financial Officer, will review the Company's business strategy and recent corporate developments.
Help employers find you! Check out all the jobs and post your resume.
